Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,310.00
-10.00 (-0.12%)
Last updated: Jun 4, 2026, 2:19 PM KST

KRX:007570 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
34,78523,6544,2953,4147,1749,288
Short-Term Investments
4,8735,9738,49510,2765,41934,111
Trading Asset Securities
-----231.78
Cash & Short-Term Investments
39,65829,62712,79013,69012,59343,631
Cash Growth
204.22%131.64%-6.57%8.72%-71.14%4.85%
Accounts Receivable
40,24244,97244,77747,65648,76252,803
Other Receivables
4,6413,9403,9364,6804,7163,297
Receivables
44,88348,91248,71352,33653,47956,101
Inventory
62,25664,24359,87353,10848,38732,423
Prepaid Expenses
541.32651.12158.02186.42303.23515.3
Other Current Assets
5,7384,3293,6524,3393,6563,671
Total Current Assets
153,076147,762125,187123,659118,418136,340
Property, Plant & Equipment
220,526220,675216,421181,973178,244175,779
Long-Term Investments
43,13040,67843,51038,57252,84745,029
Other Intangible Assets
1,7651,7121,8881,8261,9352,078
Long-Term Deferred Charges
24,50224,03923,45325,53029,48134,392
Other Long-Term Assets
22,54022,46420,56821,04621,99125,643
Total Assets
465,538457,331431,027392,607402,916419,261
Accounts Payable
19,69620,70422,32226,30729,81323,717
Accrued Expenses
440.78480.55513.8398.44310.58314.19
Short-Term Debt
82,80096,21692,50565,78971,00092,500
Current Portion of Long-Term Debt
3,3333,333--2,000-
Current Portion of Leases
445.43189.5266.59522.11370.52159.24
Current Income Taxes Payable
115.55236.41,2931,126958.543,542
Other Current Liabilities
57,15850,01240,64945,12140,87547,687
Total Current Liabilities
163,989171,172157,549139,263145,328167,920
Long-Term Debt
25,83326,66714,7006,000-5,000
Long-Term Leases
233.67388.51209.38339.24732.69843.73
Pension & Post-Retirement Benefits
7,1177,0188,5807,3227,9098,136
Long-Term Deferred Tax Liabilities
8,4058,2278,5659,23310,66210,464
Other Long-Term Liabilities
2,4302,4501,8915050021.5
Total Liabilities
208,008215,922191,494162,207165,132192,385
Common Stock
47,71447,71447,71447,71447,71447,714
Additional Paid-In Capital
78,37078,37078,37078,44178,41678,590
Retained Earnings
134,793122,790118,75953,55958,75943,170
Treasury Stock
-12,269-12,269-11,269-11,921-10,075-7,437
Comprehensive Income & Other
4,240-114.371,26457,95758,49660,587
Total Common Equity
252,848236,490234,838225,751233,311222,624
Minority Interest
3,5693,8053,5823,5363,3613,139
Shareholders' Equity
257,530241,409239,533230,400237,785226,876
Total Liabilities & Equity
465,538457,331431,027392,607402,916419,261
Total Debt
112,646126,794107,68172,65074,10398,503
Net Cash (Debt)
-72,988-97,168-94,891-58,960-61,511-54,872
Net Cash Per Share
-4142.15-5414.14-5148.09-3272.13-3393.60-3014.10
Filing Date Shares Outstanding
17.3117.9218.0117.9718.0918.21
Total Common Shares Outstanding
17.3117.9218.0117.9718.0918.21
Working Capital
-10,913-23,410-32,362-15,604-26,910-31,580
Book Value Per Share
14603.1713193.3513036.8712561.4212899.4512228.63
Tangible Book Value
251,083234,778232,951223,925231,375220,547
Tangible Book Value Per Share
14501.2213097.8512932.0712459.7912792.4612114.49
Land
118,556118,556120,507120,298120,308116,955
Buildings
39,13939,55841,12642,78744,47445,995
Machinery
2,8392,9944,0556,0609,3679,480
Construction In Progress
58,59958,41549,58311,4352,3841,953